Archives
-
Biotin-XX Tyramide Reagent for Spatial Biology
2026-08-28
Biotin-XX Tyramide Reagent converts HRP localization into a highly sensitive, membrane-restricted spatial readout for IHC and ISH. This article explains how biotin-LC-LC-tyramide can clarify cell-surface signaling and migration biology without confusing amplification with mechanistic proof.
-
FLNa–NF-κB Control of Hepatitis E Virus Replication
2026-08-27
The reference study identifies filamin A (FLNa) as a host cytoskeletal factor that connects HEV infection with NF-κB signaling, apoptosis, and inflammatory responses. Its evidence suggests that HEV-driven suppression of FLNa blocks IκB degradation and NF-κB nuclear translocation, creating conditions that favor viral replication and virion release.
-
Bleomycin Sulfate: DNA Damage to Fibrosis
2026-08-27
Bleomycin Sulfate, also known as Blenoxane, is more than a cytotoxic reagent: it is a controllable gateway from DNA strand breaks to inflammatory and fibrotic signaling. This thought-leadership guide connects mechanistic assays, pulmonary fibrosis research, and macrophage-targeted STING editing to improve translational study design.
-
Cy5 Goat Anti-Rabbit IgG (H+L) Antibody Workflow
2026-08-26
Build sensitive, reproducible fluorescence workflows for mapping ASB3–MAVS signaling across immunofluorescence, western blotting, immunohistochemistry, and flow cytometry. This guide combines mechanism-led assay design with practical dilution, storage, imaging, and troubleshooting recommendations for a Cy5 conjugated secondary antibody.
-
BRD4 Inhibition Primes Erastin-Induced Ferroptosis
2026-08-26
The 2024 Discover Oncology study shows that pharmacological or genetic BRD4 inhibition broadly sensitizes several cell lines to erastin-induced ferroptosis. Its central mechanistic contribution is linking this sensitization to reactive oxygen species accumulation and reduced FSP1 expression, while also revealing cell-specific changes in other ferroptosis regulators.
-
Early Life Adversity, Oxytocin, and Innate Defense
2026-08-25
Tan et al. report that early life adversity caused by postnatal social deprivation disrupts looming-evoked innate defensive behavior in mice through reduced oxytocin signaling in the superior colliculus. The study combines behavioral testing, receptor manipulation, circuit analysis, and intranasal oxytocin rescue to connect early experience with a specific threat-response pathway.
-
Coelenterazine for ROS and Reporter Assays
2026-08-25
Coelenterazine connects luciferase reporter readouts with chemiluminescent detection of superoxide anion and peroxynitrite. This practical guide shows how to build compatible reporter, BRET, HTS, oxidative stress, and cancer-associated ROS imaging workflows while controlling solvent, timing, and background.
-
DPPH Assay: From Radical Signal to Decisions
2026-08-24
DPPH enables rapid in vitro antioxidant screening, but its greatest value comes from interpreting radical-scavenging data alongside orthogonal chemistry and bioactivity measurements. This guide explains how to turn a DPPH result into a defensible natural-product or drug-discovery decision.
-
BMS-345541: IKK-1/IKK-2 Workflow Guide
2026-08-24
Use BMS-345541 to connect IKK activity with cytokine production, endothelial behavior, and cancer-cell survival. This practical guide translates NF-κB pathway inhibition into dose-finding, angiogenesis, inflammation, and apoptosis workflows while emphasizing controls and troubleshooting.
-
ECL Chemiluminescent Substrate Detection Kit Guide
2026-08-23
This scenario-based guide explains how ECL chemiluminescent detection can resolve low-signal and variable immunoblotting problems that arise alongside cell viability, proliferation, and cytotoxicity assays. It evaluates the ECL Chemiluminescent Substrate Detection Kit (Hypersensitive), SKU K1231, using practical criteria including sensitivity, workflow flexibility, membrane compatibility, and cost-efficiency.
-
Linoleic Acid–PPARα–TF Axis in pLELC
2026-08-22
This Research Square study integrates serum proteomics, untargeted metabolomics, functional intervention, and patient-derived xenograft validation to propose a linoleic acid–PPARα–tissue factor axis in primary pulmonary lymphoepithelioma-like carcinoma. Its findings connect lipid signals with immune-cell remodeling and tumor progression, while identifying tissue factor as a candidate therapeutic vulnerability that requires further validation.
-
Biotin-tyramide A8011: TSA Workflow Guide
2026-08-22
Biotin-tyramide (SKU A8011) is a biotin phenol reagent for HRP-driven tyramide signal amplification in fixed-cell and tissue workflows, including immunohistochemistry and in situ hybridization. It is appropriate when localized signal enhancement is needed, but it requires solvent-aware preparation and assay-specific optimization; it should not be treated as a validated diagnostic reagent.
-
Comparative Gene Expression in Mammalian Claustrum
2026-08-21
The reference study proposes a cross-species framework for identifying conserved claustrum subdivisions by integrating gene expression, cytoarchitecture, and anatomical position. Its in situ hybridization analysis across rodents, shrews, and primates supports shared molecular and spatial organization despite major differences in brain size, while also clarifying the limits of translating mouse-based claustrum research.
-
EZ Cap™ Firefly Luciferase mRNA Workflows
2026-08-20
EZ Cap™ Firefly Luciferase mRNA provides a sensitive, transient readout for delivery, translation, viability, and live-cell imaging workflows. Its Cap 1 structure and optimized poly(A) tail help researchers separate delivery performance from transcriptional variables while improving assay consistency.
-
DPPH: From Radical Signal to Bioactivity Insight
2026-08-20
DPPH is more than a rapid colorimetric antioxidant assay reagent. This guide explains how to interpret its radical-scavenging signal alongside orthogonal assays, using recent Taihangia rupestris research to improve natural product screening decisions.